Tovetumab (Anti-PDGFRA / CD140a) | PDGFR antibody | Read Reviews & Product Use Citations

Tovetumab (Anti-PDGFRA / CD140a) is a fully humanized IgG2κ monoclonal antibody directed against the platelet-derived growth factor receptor (PDGFR) alpha with potential antineoplastic activity. It has a potential to be used in research of glioblastoma and non-small cell lung cancer (NSCLC). MW :145 kD.

Purity & Quality Control

≥99

Choose Selective PDGFR Inhibitors

Biological Activity

Description	Tovetumab (Anti-PDGFRA / CD140a) is a fully humanized IgG2κ monoclonal antibody directed against the platelet-derived growth factor receptor (PDGFR) alpha with potential antineoplastic activity. It has a potential to be used in research of glioblastoma and non-small cell lung cancer (NSCLC). MW :145 kD.

References
[1] Liang M, et al. AAPS J. 2020 Nov 18;23(1):4.

References

[1] Liang M, et al. AAPS J. 2020 Nov 18;23(1):4.

Product Details

CAS No.	1243266-04-7
Molecular Weight	145
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field